$3250 | Single User
$4650 | Site License
$5650 | Global License

Pharmerging Market, By Product Types (Pharmaceuticals and Healthcare), By Geography (Tier I, Tier II and Tier III ) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270554 | In Stock
Related Topics: AstraZeneca , COVID , Drug , Finance , Healthcare , Medical , Medical Devices , Pfizer , Pharmaceuticals , Roche

Introduction

REPORT HIGHLIGHT

The Pharmerging market is estimated to represent a global market of USD 690.3 billion by 2019 with growth rate of 18.8%.

Market Dynamics

The pharmerging industry covers the study for developing countries where the use of pharmaceuticals is rapidly growing and is projected to experience strong growth in the future period. Countries such as China, India, Brazil, Russia, and South Africa among others are considered under the research scope. Drug spending in these economies is increasing at a constant rate, making them attractive targets for drug manufacturers to invest in. For instance, as per the International Federation of Pharmaceutical Manufacturers & Associations, pharmerging economies account for around 50% of absolute growth in drug spending every year.

There is a constant rise of people affected by chronic disorders due to the lifestyle changes. The number of cardiovascular, cancer, respiratory and diabetes patients are increasing monumentally. For example, cardiovascular conditions such as strokes, coronary heart disease, rheumatic heart disease, and cardiomyopathy are expected to be the major causes of mortality and morbidity in developing countries across the world. As per the World Health Organization statistics, more than 80% of cardiovascular deaths occur in low to middle-income countries. Additionally, an aging population, higher standards of living and advancement in technologies in the medical sector have led to a sharp increase in life expectancy. As a consequence, longer-lived individuals will create upward pressure on demand for pharmaceuticals & healthcare services. All such facts would in turn open up a new market for healthcare treatment that have traditionally been targeted at developed region patients.

COVID-19 Impact

The sudden challenges created by the ongoing COVID-19 outbreak are well-captured to exhibit the long term pharmerging market growth projections. The pharmerging industry growth sectors are identified with precision for a better growth perspective considering the political, economical and social impact of COVID-19 virus ourbreak.

Product Types Takeaway

In terms of product types, the industry is divided into Pharmaceuticals and Healthcare. Pharmaceuticals segment is further categorized as Patented, Generic and Over-the-Counter Therapeutics. In 2017, generic pharmaceuticals recorded USD 198.7 billion and the segment is projected to grow with strong CAGR during the future period. Healthcare segment is bifurcated as Medical Devices, In-Vitro Diagnostics, and others.

Regional Takeaway

Geographically, the industry is broadly categorized into Tier I, Tier II and Tier III economies. Chinese pharmerging market covers under the Tier I category which is considered one amongst the highest revenue generating country. In 2017, this category has captured over 52% of the worldwide market. According to China’s Ministry of Finance (MOF), healthcare expenditure in the country has increased by 10% in 2016. Due to this fact, out-of-pocket spending for healthcare needs in China has decreased, as the penetration of insurance has increased. As of 2015, almost 95.0% of the population is enrolled in at least one public health insurance scheme.

Tier II category include a detailed study for BRICS countries (except China) such as India, Russia, Brazil and South Africa. India and Brazil collectively accounted for over 60% revenue share of the countries considered under Tier II economy. As per the Pharmaceutical Export Promotion Council of India (PHARMEXCIL), the national pharmaceutical exports are projected to reach USD 20 million by 2020. The Indian pharmaceutical sector is highly fragmented with the presence of more than 15,000 manufactures. Tier III includes extensive qualitative and quantitative study for Turkey, Poland, Mexico, Argentina, Thailand, and Saudi Arabia. These countries represent a wide range of incomes, and GDP Mexico recorded USD 22.9 billion in 2017 and is projected to grow by over 8% CAGR during the study period.

Key Vendor Takeaway

Companies namely Pfizer, Inc., AstraZeneca, Roche, GE Healthcare, and Medtronic are actively operating in this industry. Attributes such as company overview, financials, product benchmarking and key initiatives were discussed separately. Key players are engaged in strategic collaborations to capture untapped market opportunities. For instance, in July 2017, AstraZeneca collaborated with Merck, Inc. to potential cancer therapeutic, MEK and PARP inhibitors in combination with PD-L1 medicines.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2021-2027

TARGET AUDIENCE

The scope of this report covers the market by its major segments, which include as follows:

PHARMERGING MARKET, BY PRODUCT TYPES

Pharmaceuticals

Patented

Generic

Over-the-Counter

Healthcare

Medical Devices

In-Vitro Diagnostics

Others

PHARMERGING MARKET, BY REGION

Tier I

China

Tier II

India

Russia

Brazil

South Africa

Tier III

Turkey

Poland

Mexico

Argentina

Thailand

Saudi Arabia

Table of Contents
for Pharmerging Market, By Product Types (Pharmaceuticals and Healthcare), By Geography (Tier I, Tier II and Tier III ) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    1. PHARMERGING MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. PHARMERGING KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. PHARMERGING INDUSTRY STUDY

    4.1. Porter’s Analysis

    4.2. Market Attractiveness Analysis

    4.3. Regulatory Framework Analysis

    4.4 PHARMERGING MARKET: COVID-19 IMPACT ANALYSIS

    4.4.1 Pre-COVID-19 Impact Analysis

    4.4.2 Post-COVID-19 Impact Analysis

    4.4.3 Top Performing Segments

    4.4.4 Marginal Growth Segments

    4.4.5 Top Looser Segments

    4.4.6 Marginal Loss Segments

    5. PHARMERGING MARKET LANDSCAPE

    5.1. Market Share Analysis

    6. PHARMERGING MARKET – BY PRODUCT TYPES

    6.1. Overview

    6.2. Pharmaceuticals

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.2.3. Patented

    6.2.3.1. Overview

    6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.2.4. Generic

    6.2.4.1. Overview

    6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.2.5. Over-the-Counter

    6.2.5.1. Overview

    6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.3. Healthcare

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.3.3. Medical Devices

    6.3.3.1. Overview

    6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.3.4. In-Vitro Diagnostics

    6.3.4.1. Overview

    6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    6.3.5. Others

    6.3.5.1. Overview

    6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7. PHARMERGING MARKET– BY GEOGRAPHY

    7.1. Introduction

    7.2. Tier I

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.2.3. China

    7.2.3.1. Overview

    7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3. Tier II

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3.3. India

    7.3.3.1. Overview

    7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3.4. Russia

    7.3.4.1. Overview

    7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3.5. Brazil

    7.3.5.1. Overview

    7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.3.6. South Africa

    7.3.6.1. Overview

    7.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4. Tier III

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.3. Turkey

    7.4.3.1. Overview

    7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.4. Poland

    7.4.4.1. Overview

    7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.5. Mexico

    7.4.5.1. Overview

    7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.6. Argentina

    7.4.6.1. Overview

    7.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.7. Thailand

    7.4.7.1. Overview

    7.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    7.4.8. Saudi Arabia

    7.4.8.1. Overview

    7.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016-2027, (US$ Billion)

    8. KEY VENDOR ANALYSIS

    8.1. Pfizer, Inc.

    8.1.1. Company Overview

    8.1.2. SWOT Analysis

    8.1.3. Key Developments

    8.2. AstraZeneca

    8.2.1. Company Overview

    8.2.2. SWOT Analysis

    8.2.3. Key Developments

    8.3. Roche

    8.3.1. Company Overview

    8.3.2. SWOT Analysis

    8.3.3. Key Developments

    8.4. GE Healthcare

    8.4.1. Company Overview

    8.4.2. SWOT Analysis

    8.4.3. Key Developments

    8.5. Medtronic

    8.5.1. Company Overview

    8.5.2. SWOT Analysis

    8.5.3. Key Developments

    9. 360 DEGREE ANALYSTVIEW

    10. APPENDIX

    10.1. Research Methodology

    10.2. Abbreviations

    10.3. Disclaimer

    10.4. Contact Us

List Of Tables
in Pharmerging Market, By Product Types (Pharmaceuticals and Healthcare), By Geography (Tier I, Tier II and Tier III ) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Pharmerging Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Billion)

Table 10 Pharmerging Market, by Product Types, 2016 – 2027 (USD Billion)

Table 11 Pharmerging Market, by Geography, 2016 – 2027 (USD Billion)

Table 12 Tier I Pharmerging Market, 2016 – 2027 (USD Billion)

Table 13 China Pharmerging Market, 2016 – 2027 (USD Billion)

Table 14 Tier II Pharmerging Market, 2016 – 2027 (USD Billion)

Table 15 India Pharmerging Market, 2016 – 2027 (USD Billion)

Table 16 Russia Pharmerging Market, 2016 – 2027 (USD Billion)

Table 17 Brazil Pharmerging Market, 2016 – 2027 (USD Billion)

Table 18 South Africa Pharmerging Market, 2016 – 2027 (USD Billion)

Table 19 Tier III Pharmerging Market, 2016 – 2027 (USD Billion)

Table 20 Turkey Pharmerging Market, 2016 – 2027 (USD Billion)

Table 21 Poland Pharmerging Market, 2016 – 2027 (USD Billion)

Table 22 Mexico Pharmerging Market, 2016 – 2027 (USD Billion)

Table 23 Argentina Pharmerging Market, 2016 – 2027 (USD Billion)

Table 24 Thiland Pharmerging Market, 2016 – 2027 (USD Billion)

Table 25 Soudi Arabia Pharmerging Market, 2016 – 2027 (USD Billion)

List Of Figures, Charts and Diagrams
in Pharmerging Market, By Product Types (Pharmaceuticals and Healthcare), By Geography (Tier I, Tier II and Tier III ) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methodology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Pharmerging Market, by Product Types, 2016 – 2027 (USD Billion)

Figure 6 Pharmerging Market, by Geography, 2016 – 2027 (USD Billion)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270554 | AV198

Number of Pages

206

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Pharmerging Market: By Geography (Tier I Countries, Tier II Countries, and Tier III Countries)--Forecast (2016-2021)
Globally, growing global pharmaceutical market, rise in public and private healthcare insurance, ris...
05 Jan 2016 by USD $5,250 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Pharmerging Market, By Product Types (Pharmaceuticals and Healthcare), By Geography (Tier I, Tier II and Tier III ) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...